A neuroprotective dose of trehalose is harmless to metabolic organs: comprehensive histopathological analysis of liver, pancreas, and kidney.
Diego Armando Morales-CarrizalesYareth Gopar-CuevasMaría de Jesús Loera AriasOdila Saucedo-CárdenasRoberto Montes de Oca-LunaAracely Garcia-GarciaHumberto Rodríguez-RochaPublished in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Our study demonstrates that systemic trehalose administration preserved the typical histological architecture of the organs involved in its metabolism, supporting its safety as a potential neuroprotective agent.